BackgroundElectroconvulsive therapy (ECT) is one of the most effective treatments for
depression, although the underlying mechanisms remain unclear. Animal studies have shown …

Electroconvulsive therapy (ECT) is the most effective treatment for severe depression, although
the underlying mechanisms remain unclear. Animal studies have consistently shown that …

Recent genome-wide association studies have demonstrated that the genetic burden
associated with depression correlates with depression severity. Therefore, conducting genetic …

Alterations in glutamatergic neurotransmission are implicated in the pathophysiology of
depression, and the glutamatergic system represents a treatment target for depression. To …

Background Actigraphy has enabled consecutive observation of individual health conditions
such as sleep or daily activity. This study aimed to examine the usefulness of actigraphy in …

Background The COVID-19 pandemic has altered daily routines and family functioning, led
to closing schools, and dramatically limited social interactions worldwide. Measuring its …

Background Electroconvulsive therapy (ECT) is a well‐established treatment for psychiatric
disorders, including depression and psychosis. ECT has been reported to be effective in …

Background Electroconvulsive therapy (ECT) is associated with volumetric enlargements of
corticolimbic brain regions. However, the pattern of whole-brain structural alterations …

Objective We aimed to develop a machine learning algorithm to screen for depression and
assess severity based on data from wearable devices. Methods We used a wearable device …

Background There are no reliable and validated objective biomarkers for the assessment of
depression severity. We aimed to investigate the association between depression severity …